Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 6
2022 3
2023 4
2024 8
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean tiossi r (51 results)?
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
Howard JF Jr, Bril V, Vu T, Karam C, Peric S, Margania T, Murai H, Bilinska M, Shakarishvili R, Smilowski M, Guglietta A, Ulrichts P, Vangeneugden T, Utsugisawa K, Verschuuren J, Mantegazza R; ADAPT Investigator Study Group. Howard JF Jr, et al. Lancet Neurol. 2021 Jul;20(7):526-536. doi: 10.1016/S1474-4422(21)00159-9. Lancet Neurol. 2021. PMID: 34146511 Clinical Trial.
Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis.
Giossi R, Menichelli D, D'Amico F, Idotta L, Cirino M, Scardoni L, Furlanetto C, Maggi M, Bernocchi O, Bosca F, Girlando L, Pignatelli P, Pani A, Pastori D, Tozzo A, Scaglione F, Fornasari D. Giossi R, et al. J Thromb Haemost. 2023 Oct;21(10):2784-2796. doi: 10.1016/j.jtha.2023.07.011. Epub 2023 Jul 20. J Thromb Haemost. 2023. PMID: 37481075 Free article.
Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG Study.
Antozzi C, Guptill J, Bril V, Gamez J, Meuth SG, Nowak RJ, Quan D, Sevilla T, Jouvin MH, Jin J, Karcher K, Ramchandren S, Sun H, Ling L, Zhu Y, Arroyo S; Vivacity-MG Phase 2 Study Group. Antozzi C, et al. Neurology. 2024 Jan 23;102(2):e207937. doi: 10.1212/WNL.0000000000207937. Epub 2023 Dec 21. Neurology. 2024. PMID: 38165333 Free PMC article. Clinical Trial.
Reducing the Impact of Headache and Allodynia Score in Chronic Migraine: An Exploratory Analysis from the Real-World Effectiveness of Anti-CGRP Monoclonal Antibodies Compared to Onabotulinum Toxin A (RAMO) Study.
Montisano DA, Giossi R, Canella M, Altamura C, Marcosano M, Vernieri F, Raggi A, Grazzi L. Montisano DA, et al. Among authors: giossi r. Toxins (Basel). 2024 Apr 7;16(4):178. doi: 10.3390/toxins16040178. Toxins (Basel). 2024. PMID: 38668603 Free PMC article.
Deep brain stimulation in Huntington's disease: a literature review.
Bonomo R, Elia AE, Bonomo G, Romito LM, Mariotti C, Devigili G, Cilia R, Giossi R, Eleopra R. Bonomo R, et al. Among authors: giossi r. Neurol Sci. 2021 Nov;42(11):4447-4457. doi: 10.1007/s10072-021-05527-1. Epub 2021 Sep 1. Neurol Sci. 2021. PMID: 34471947 Review.
19 results